Bioavailability of diclofenac after intramuscular administration to rats with experimental spinal cord injury

Journal of Pharmacological and Toxicological Methods

Volumn 42, Issue 2, 1999, Pages 99-101

  García López, Patricia ^c   Salas, Rebeca ^a,b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

Bioavailability; Diclofenac; Pharmacokinetics; Spinal cord injury

Indexed keywords

DICLOFENAC;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMB BLOOD FLOW; NONHUMAN; RAT; SPINAL CORD INJURY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL AVAILABILITY; DICLOFENAC; FEMALE; INJECTIONS, INTRAMUSCULAR; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES;

ANIMALIA;

EID: 0343962637     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8719(00)00049-6     Document Type: Article

References (17)

1. Allen A.R. Surgery of experimental lesions of spinal cord equivalent to crush injury of fracture dislocation of spinal column. a preliminary report J Am Med Assoc. 57:1911;878-880.
2. Fealey R.D., Szurszewski J.H., Merrit J.L., DiMagno E.P. Effect of traumatic spinal cord transection on human upper gastrointestinal motility and gastric emptying. Gastroenterology. 87:1984;69-75.
3. García-López P., Pérez-Urizar J., Ibarra A., Guízar-Sahagún G., Flores-Murrieta F.J., Grijalva I., Castañeda-Hernández G. An experimental model for the study of pharmacokinetic alterations induced by spinal cord injury. Pharm Sci. 1:1995;133-135.
4. García-López P., Pérez-Urizar J., Ibarra A., Grijalva I., Madrazo I., Flores-Murrieta F.J., Castañeda-Hernández G., Guízar-Sahagún G. Comparison between Sprague-Dawley and Wistar rats as an experimental model of pharmacokinetic alterations induced by spinal cord injury. Arch Med Res. 27:1996;453-457.
5. García-López P., Pérez-Urizar J., Madrazo I., Guízar-Sahagún G., Castañeda-Hernández G. Oral paracetamol bioavailability in rats subjected to experimental spinal cord injury. Biopharm Drug Dispos. 18:1997;203-211.
6. García-López P., Guízar-Sahagún G., Castañeda-Hernández G. Effects of high and low thoracic spinal cord injury on the oral pharmacokinetics of paracetamol in rats. Pharm Pharmacol Commun. 5:1999;579-581.
7. Guízar-Sahagún G., Grijalva I., Madrazo I., Franco-Bourland R., Salgado-Ceballos H., Ibarra A., Larriva-Sahd J. Neuroprotection of completely lacerated spinal cord of adult rats by homotropic and heterotropic transplantation. Rest Neurol Neurosci. 7:1994;61-70.
8. Guízar-Sahagún G., García-López P., Espitia A.L., Méndez S., Castañeda-Henández G., Madrazo I., Franco-Bourland R. Histochemical evidence for the increased expression of nicotinamide adenine dinucleotide phosphate-dependent diaphorase in neurons of the myenteric plexus after acute spinal cord injury in adult rats. Neurosci Lett. 206:1996;185-188.
9. Guízar-Sahagún G., Castañeda-Hernández G., García-López P., Franco-Bourland R., Grijalva I., Madrazo I. Pathophysiological mechanisms involved in systemic and metabolic alterations secondary to spinal cord injury. Proc West Pharmacol Soc. 41:1998;237-240.
10. Halstead L.S., Feldman S., Claus-Walker J., Patel V.C. Drug absorption in spinal cord injury. Arch Phys Med Rehab. 66:1985;298-301.
11. Ibarra A., Guízar-Sahagún G., Correa D., Kretschmer R., Grijalva I., Flores-Murrieta F.J., Castañeda-Hernández G., Odor A., López R.M., Franco-Bourland R., Espitia A.L., Salgado-Ceballos H., Madrazo I. Alteration of cyclosporin-A pharmacokinetics after experimental spinal cord injury. J Neurotrauma. 5:1996;267-272.
12. Segal J.L. Clinical pharmacology of spinal cord injury. Young R.R., Woolsey R.M. Diagnosis and Management of Disorders of the Spinal Cord. 1995;414-438 Saunders, Philadelphia.
13. Segal J.L., Brunnemann S.R. Clinical pharmacokinetics in patients with spinal cord injury. Clin Pharmacokinet. 17:1989;109-129.
14. Segal J.L., Brunnemann S.R., Gordon S.K., Eltorai I.M. Decreased theophylline bioavailability and impaired gastric emptying in spinal cord injury. Curr Ther Res. 38:1985;831-846.
15. Segal J.L., Brunnemann S.R., Gordon S.K., Eltorai I.M., Gray D.R. Impaired absorption of intramuscularly administered gentamicin in spinal cord injury. Curr Ther Res. 39:1986;961-969.
16. Seifert J., Lob G., Stoephasius E., Probst J., Brendel W. Blood flow in muscles of paraplegic patients under various conditions measured by a double isotope technique. Paraplegia. 10:1972;185-191.
17. Torres-López J.E., Robles M.B., Pérez-Urizar J., Flores-Murrieta F.J., Granados-Soto V. Determination of diclofenac in micro-whole blood samples by high-performance liquid chromatography with electrochemical detection. application in a pharmacokinetic study Arzneim-Forsch. 47:1997;1040-1043.